Skip to main content

A community pharmacy-based cardiovascular screening service: Views of service users and the public

Taylor, Julia, Krska, Janet, MacKridge, Adam (2012) A community pharmacy-based cardiovascular screening service: Views of service users and the public. International Journal of Pharmacy Practice, 20 (5). pp. 277-284. ISSN 0961-7671. (doi:10.1111/j.2042-7174.2012.00190.x) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:31758)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.
Official URL:
http://dx.doi.org/10.1111/j.2042-7174.2012.00190.x

Abstract

Objectives To determine whether pharmacy-based cardiovascular disease (CVD) screening reached the desired population, the local population's awareness of pharmacy screening and the views of service users and the general public about CVD screening. Methods: Pharmacy staff, located in one English Primary Care Trust providing a CVD screening service, issued questionnaires to service users who had undergone screening. Face-to-face street surveys were conducted with members of the general public within the vicinity of each participating pharmacy. Key findings A total of 259 people were screened within the first 6 months of service provision, 97 of whom (37.4%) completed the evaluation questionnaire. In addition, 261 non-service users participated in street surveys. Most respondents among both service users and non-users had at least one risk factor for cardiovascular disease, including smoking and lack of exercise. Responses to statements regarding CVD screening showed a high level of agreement with the need for screening in both groups. However, significantly more service users (90.7%) agreed that a pharmacy was a good place for screening compared to the non-users (77.4%; P < 0.005). Likewise significantly fewer service users agreed that screening should be only carried out by doctors (10.3 compared to 25.3% of non-users; P < 0.005). The overall majority of service users 96 (99.7%) had a positive experience of the screening service, agreeing that they were given enough time and pharmacists made them feel at ease. Only 9% of non-users were aware of the pharmacy service and, although the majority (78.4%) were willing to be screened at a pharmacy, this was significantly lower among males than females (69.9 compared to 82.7%; P < 0.005). Perceived concerns about confidentiality and lack of privacy were among barriers identified to taking up screening. Conclusion: Pharmacy-based CVD screening is acceptable to the public. Its uptake could be improved through increased awareness of the service and by addressing concerns about privacy and confidentiality in promotional activities.

Item Type: Article
DOI/Identification number: 10.1111/j.2042-7174.2012.00190.x
Uncontrolled keywords: cardiovascular disease, community pharmacy services, public health, screening, adult, aged, alcohol consumption, cardiovascular risk, confidentiality, diet, drinking behavior, health status, lifestyle, pharmacist, pharmacy, privacy, smoking
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Janet Krska
Date Deposited: 19 Oct 2012 11:17 UTC
Last Modified: 16 Nov 2021 10:09 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/31758 (The current URI for this page, for reference purposes)

University of Kent Author Information

  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.